Bugleweed
LamiaceaeLycopus virginicus
Also known as: Virginia Bugleweed, Water Horehound, Sweet Bugle
clinical_notes Clinical Summary
Bugleweed (Lycopus virginicus) is a Lamiaceae nervine and antithyroid herb used primarily for mild hyperthyroidism, Graves' disease, and associated tachycardia, palpitations, and anxiety.
Its rosmarinic acid and related phenolic acids inhibit TSH receptor binding, block Graves' immunoglobulins, and reduce peripheral T4-to-T3 deiodination.
It is contraindicated in hypothyroidism, pregnancy, lactation, and patients taking thyroid hormone replacement.
Pregnancy Safety
Contraindicated. Antigonadotropic and antithyroid; preclinical evidence of endocrine disruption.
Lactation Safety
Contraindicated. Suppresses prolactin and may reduce milk supply.
warning Contraindications
- Hypothyroidism (contraindicated)Theoretical
- Pregnancy (contraindicated)Theoretical
- Lactation (contraindicated)Theoretical
- Concurrent thyroid hormone replacement (levothyroxine) (contraindicated)Theoretical
- Goiter without functional disorder / enlarged thyroid (avoid)Theoretical
- Thyroid radioisotope diagnostic procedures (avoid)Theoretical
vital_signs Clinical Profile
Primary Indications
- check_circle mild hyperthyroidism
- check_circle Graves' disease (adjunctive)
- check_circle tachycardia of hyperthyroid origin
- check_circle palpitations
- check_circle anxiety with cardiac symptoms
- check_circle cyclic mastalgia
- check_circle premenstrual breast tenderness
- check_circle irritating cough with hemoptysis
Therapeutic Actions
System Affinities
- check_circle thyroid
- check_circle cardiovascular
- check_circle nervous system
- check_circle respiratory
labs Active Constituents
rosmarinic acid
lithospermic acid
chlorogenic acid
caffeic acid
flavonoids
phenolic acids
essential oil
tannins
history_edu Traditional Use
No TCM data available for this herb yet.
Traditional Uses Across Healing Systems
While many herbs lack controlled clinical trials, centuries of traditional practice across cultures provide valuable insight into their therapeutic applications.
Eclectic and modern herbal use for mild hyperthyroidism, Graves' disease (adjunctive), tachycardia, palpitations, and irritating cough with bloody sputum.
Often used interchangeably with European Lycopus europaeus (Gypsywort). Modern German phytotherapy uses standardized preparations (Thyreogutt mono).
Cherokee and other Native American use as a sedative, mild astringent for diarrhea, and as a cough remedy.
spa Parts Used
aerial parts (leaf and flower)
- mild hyperthyroidism
- Graves' disease
- tachycardia
- palpitations
- cyclic mastalgia
Whole flowering aerial parts harvested in summer just before flower buds open. Dried for tincture or freeze-dried for highest activity (freeze-drying preserves auto-oxidized active constituents).
shield Safety
Contraindications — Evidence Basis
Hypothyroidism
Suppresses TSH, T3, and T4 and inhibits peripheral T4-to-T3 conversion; will worsen hypothyroid state.
Pregnancy
Antigonadotropic activity (lowers LH, FSH); may interfere with normal endocrine function in pregnancy; potential adverse fetal effects from altered maternal thyroid status.
Lactation
Inhibits prolactin secretion and may reduce breast milk supply.
Concurrent thyroid hormone replacement (levothyroxine)
Bugleweed inhibits exogenous as well as endogenous thyroid hormone activity; will antagonize levothyroxine.
Goiter without functional disorder / enlarged thyroid
Long-term or high-dose use may further enlarge non-functional goiter.
Thyroid radioisotope diagnostic procedures
May interfere with iodide uptake and skew diagnostic imaging or radioiodine therapy.
Monitoring Parameters
Monitor during use, especially with prolonged or high-dose therapy.
TSH, free T4, free T3
Baseline, at 4-6 weeks, then every 3 months during useBugleweed suppresses TSH and reduces thyroid hormone output; monitoring ensures therapeutic effect without inducing hypothyroidism.
flagThreshold: TSH >5 mIU/L or symptomatic hypothyroidism: reduce dose or discontinue. TSH <0.1 mIU/L while still hyperthyroid: continue and reassess.
TSI / TRAb (Graves' antibodies)
Every 3-6 months when used for Graves' diseaseBugleweed extract may reduce TSI titers via blockade of Graves' IgG-receptor binding; monitoring antibody titers helps assess immunomodulatory effect.
flagThreshold: Falling TSI/TRAb suggests therapeutic response.
Resting heart rate, blood pressure
Weekly initially, then monthlyBugleweed reduces beta-adrenoceptor density and slows tachycardia of hyperthyroidism.
flagThreshold: Resting HR persistently <60 bpm or symptomatic bradycardia: reduce dose.
Toxicity
No specific toxic dose established. Doses up to 2 g/day have been well tolerated in clinical reports.
Symptoms of induced hypothyroidism with chronic high-dose use: fatigue, weight gain, cold intolerance, depression.
Discontinue use; thyroid function panel; rebound hyperthyroidism has been reported after abrupt discontinuation in Graves' patients — taper gradually.
Adverse Effects
CYP Metabolism
No significant CYP interactions documented. Rosmarinic acid is metabolized primarily via glucuronidation and methylation, not CYP450.
swap_horiz Interactions
Beta-blockers (propranolol, atenolol, metoprolol)
Class: Beta-adrenergic antagonist
Lycopus extract reduces cardiac beta-adrenoceptor density in animal models and improves cardiac symptoms (tachycardia, palpitations) in mild hyperthyroidism, similar to beta-blocker action. Additive bradycardia and hypotension possible.
Monitor heart rate and blood pressure when initiating combination. May allow beta-blocker dose reduction in stable Graves' disease.
Levothyroxine / Liothyronine
Class: Thyroid hormone replacement
Rosmarinic, lithospermic, and chlorogenic acids in Lycopus form oxidative adducts with TSH and inhibit TSH-receptor binding and adenylate cyclase activation in thyroid follicular cells. Bugleweed also inhibits peripheral 5'-deiodinase activity, reducing T4-to-T3 conversion. Antagonism of exogenous thyroid hormone effect is well-documented.
Avoid concurrent use in patients on thyroid hormone replacement. If hypothyroid, do not use bugleweed. Monitor TSH and free T4 if inadvertently combined; expect rising TSH and falling free T4.
Antithyroid drugs (methimazole, propylthiouracil)
Class: Antithyroid
Bugleweed augments antithyroid medication effect by inhibiting TSH and Graves' immunoglobulin binding to TSH receptors, reducing peripheral T4 deiodination, and decreasing serum thyroid hormone levels. Risk of additive iatrogenic hypothyroidism.
If combined with methimazole or PTU in Graves' disease, monitor TSH, free T4, and free T3 every 4-6 weeks. Be prepared to reduce antithyroid drug dose.
Radioactive iodine (I-131)
Class: Diagnostic/therapeutic agent
Lycopus inhibits thyroid iodide uptake and TSH-driven thyroid stimulation. May interfere with diagnostic thyroid scans and reduce efficacy of radioactive iodine ablation therapy for hyperthyroidism or thyroid cancer.
Discontinue bugleweed at least 2-4 weeks before scheduled radioiodine scan or therapy. Inform endocrinologist of any herbal use.
Hormonal contraceptives / HRT
Class: Hormonal therapy
Lycopus has antigonadotropic activity in animal models, inhibiting LH and FSH secretion, and prolactin. Theoretical interaction with exogenous estrogens, progestins, and gonadotropin-related therapies (fertility treatment).
Avoid in women trying to conceive or undergoing fertility treatment. Limited clinical data exist for contraceptive efficacy interference, but caution is reasonable.
hub Combinations
Synergistic pairings can enhance therapeutic outcomes, while knowing suitable substitutes helps when specific herbs are unavailable or contraindicated.
Possible Substitutes
1Rosemary
Limited EvidenceRosemary (Salvia rosmarinus) contains similar rosmarinic and lithospermic acids and exerts comparable antithyroid effects in vitro; can be substituted where bugleweed unavailable.
In vitro studies demonstrate rosmarinic acid is the active TSH-blocking principle.
Synergistic Combinations
3Chinese Skullcap
Traditional UseChinese skullcap (Scutellaria baicalensis) modulates autoimmune inflammation in Graves'; combined with bugleweed for autoimmune-driven hyperthyroidism.
Traditional Chinese-Western integrative use for Graves' disease.
Lemon Balm
Limited EvidenceBoth contain rosmarinic acid and inhibit TSH receptor binding; lemon balm adds anxiolytic GABAergic action while supporting bugleweed's antithyroid effect. Most documented combination for Graves' disease.
Two-patient case series of Graves' hyperthyroidism showed normalization of TSH and TSI with bugleweed-lemon balm tincture; restoration of euthyroidism without need for methimazole.
Motherwort
Traditional UseMotherwort's cardiac glycoside-like and parasympathetic-toning effects complement bugleweed for hyperthyroid tachycardia, palpitations, and anxiety.
Classical Eclectic and modern German phytotherapy pairing for hyperthyroidism with cardiac symptoms.
Traditional Pairings
1Passionflower
Traditional UsePassionflower's GABAergic anxiolytic action supports anxiety, insomnia, and restlessness associated with hyperthyroidism.
Traditional Western herbal blend for hyperthyroid anxiety.
science Studies
No studies match your criteria.
medication Dosing
tincture
1-3 mL of 1:5 tincture in 45% ethanol
TID
Traditional Eclectic dose. Begin at lower end and titrate based on symptoms and thyroid labs. Best taken between meals.
capsule
100-400 mg dried herb
2-3x/day
Doses up to 2 g/day total have been well tolerated in clinical studies. Combine with lemon balm and motherwort for hyperthyroid symptoms.
tea
1-2 g dried herb in 250 mL water
TID
Cold infusion or short hot infusion (5 minutes) preserves heat-labile rosmarinic acid. Less potent than tincture or standardized extract.
Disclaimer: This information is largely AI-generated and reviewed by human experts at Evara Health. It is intended for educational and clinical reference purposes only and should not replace professional medical advice.
© 2026 Evara Health. All rights reserved.